Business Standard

Monday, December 23, 2024 | 04:55 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

DTAB to review 19 fixed-dose combinations drugs, codeine formulations today

CDSCO aims to phase out these combinations and codeine-based drugs in a phased manner

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
Premium

Sohini Das Mumbai
The Drugs Technical Advisory Board (DTAB) is likely to meet on Monday to decide the fate of 19 fixed-dose combinations (FDCs) drugs that are considered 'irrational combinations'.  

Some of the common medicine brands which are under the scanner include cough syrup Ascoril C, TeddyKoff, and some cold medicines like D'Cold Total, Dolo Cold, headache medicines like Saridon etc.

The drugmakers have been asked to generate additional data on these drugs through phase-4 trials (trials done after marketing approval). The Drugs Controller General of India (DCGI) feels that additional data is required for these drugs, and thus pharma companies have been

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in